These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31550737)

  • 21. T2 mapping of molecular subtypes of WHO grade II/III gliomas.
    Kern M; Auer TA; Picht T; Misch M; Wiener E
    BMC Neurol; 2020 Jan; 20(1):8. PubMed ID: 31914945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.
    Compes P; Tabouret E; Etcheverry A; Colin C; Appay R; Cordier N; Mosser J; Chinot O; Delingette H; Girard N; Dufour H; Metellus P; Figarella-Branger D
    J Neurooncol; 2019 May; 142(3):511-520. PubMed ID: 30756272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent Diagnostic Under-Grading in Isocitrate Dehydrogenase Wild-Type Gliomas due to Small Pathological Tissue Samples.
    Gutt-Will M; Murek M; Schwarz C; Hewer E; Vulcu S; Beck J; Raabe A; Schucht P
    Neurosurgery; 2019 Nov; 85(5):689-694. PubMed ID: 30335178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
    Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP
    J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading.
    Cadrien C; Sharma S; Lazen P; Licandro R; Furtner J; Lipka A; Niess E; Hingerl L; Motyka S; Gruber S; Strasser B; Kiesel B; Mischkulnig M; Preusser M; Roetzer-Pejrimovsky T; Wöhrer A; Weber M; Dorfer C; Trattnig S; Rössler K; Bogner W; Widhalm G; Hangel G
    Cancer Imaging; 2024 May; 24(1):67. PubMed ID: 38802883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
    J Neurosurg; 2020 Feb; 132(2):518-529. PubMed ID: 30717057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated progression of IDH mutant glioma after first recurrence.
    Miller JJ; Loebel F; Juratli TA; Tummala SS; Williams EA; Batchelor TT; Arrillaga-Romany I; Cahill DP
    Neuro Oncol; 2019 May; 21(5):669-677. PubMed ID: 30668823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
    Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ
    Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
    Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
    Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.
    Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y
    J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
    Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo Metabolic Profiles as Determined by
    Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
    Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional MR-based Preoperative Nomograms for Prediction of IDH/1p19q Subtype in Low-Grade Glioma.
    Liu Z; Zhang T; Jiang H; Xu W; Zhang J
    Acad Radiol; 2019 Aug; 26(8):1062-1070. PubMed ID: 30393056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
    Aoki K; Nakamura H; Suzuki H; Matsuo K; Kataoka K; Shimamura T; Motomura K; Ohka F; Shiina S; Yamamoto T; Nagata Y; Yoshizato T; Mizoguchi M; Abe T; Momii Y; Muragaki Y; Watanabe R; Ito I; Sanada M; Yajima H; Morita N; Takeuchi I; Miyano S; Wakabayashi T; Ogawa S; Natsume A
    Neuro Oncol; 2018 Jan; 20(1):66-77. PubMed ID: 29016839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.
    Riva M; Lopci E; Castellano A; Olivari L; Gallucci M; Pessina F; Fernandes B; Simonelli M; Navarria P; Grimaldi M; Rudà R; Castello A; Rossi M; Alfiero T; Soffietti R; Chiti A; Bello L
    World Neurosurg; 2019 Jun; 126():e270-e280. PubMed ID: 30797926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions.
    Dono A; Ballester LY; Primdahl D; Esquenazi Y; Bhatia A
    Curr Oncol Rep; 2021 Jan; 23(2):20. PubMed ID: 33492489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.